Researchers Identified How CBD Prevents Seizures: By Blocking a Lipid That Tips the Brain Toward Overexcitation
CBD prevents seizures by blocking the effects of lysophosphatidylinositol (LPI), an endogenous lipid that simultaneously increases excitatory signaling and weakens inhibitory signaling at hippocampal synapses through the GPR55 receptor.
Quick Facts
What This Study Found
LPI increased excitatory presynaptic release probability and evoked synaptic strength in hippocampal CA3-CA1 connections while simultaneously weakening inhibitory signaling by decreasing GABA receptor (GABAARgamma2) and gephyrin puncta. CBD pre-treatment eliminated all LPI effects. Acute seizures elevated both GPR55 and LPI levels. Chronic epileptogenesis potentiated LPI's pro-excitatory effects.
Key Numbers
LPI increased excitatory release probability and evoked synaptic strength. LPI decreased GABAARgamma2 and gephyrin puncta. Effects eliminated by CBD and absent in GPR55 knockout mice. Acute seizures elevated GPR55 and LPI levels.
How They Did This
Electrophysiology and immunohistochemistry in wild-type and GPR55 knockout mice. Acute (pentylenetetrazole) and chronic (lithium-pilocarpine) seizure models. Hippocampal slice recordings.
Why This Research Matters
This is among the most mechanistically detailed explanations of how CBD stops seizures. By showing that CBD blocks a single pathway (LPI-GPR55) that simultaneously tips both excitatory and inhibitory signaling toward hyperexcitability, it provides a unified mechanism for CBD's anti-seizure action.
The Bigger Picture
Understanding exactly how CBD prevents seizures could lead to more targeted anti-epileptic drugs. If the LPI-GPR55 pathway is the primary mechanism, drugs that specifically block GPR55 could potentially replicate CBD's benefits without its complex pharmacology and drug interactions.
What This Study Doesn't Tell Us
Mouse hippocampal slice model may not capture all mechanisms relevant to human epilepsy. Two seizure models tested but may not represent all epilepsy types. CBD has many known molecular targets; GPR55 may be one of several relevant pathways.
Questions This Raises
- ?Would a selective GPR55 antagonist be as effective as CBD for epilepsy with fewer drug interactions?
- ?Is the LPI-GPR55 pathway disrupted in human epilepsy patients?
Trust & Context
- Key Stat:
- CBD blocks a single pathway that tips both excitation and inhibition toward seizures
- Evidence Grade:
- Rigorous mechanistic study published in Neuron using knockout mice and multiple epilepsy models. Strong evidence for this specific mechanism.
- Study Age:
- Published in 2023 in Neuron.
- Original Title:
- Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.
- Published In:
- Neuron, 111(8), 1282-1300.e8 (2023)
- Authors:
- Rosenberg, Evan C(3), Chamberland, Simon(2), Bazelot, Michael, Nebet, Erica R, Wang, Xiaohan, McKenzie, Sam, Jain, Swati, Greenhill, Stuart, Wilson, Max, Marley, Nicole, Salah, Alejandro, Bailey, Shanice, Patra, Pabitra Hriday, Rose, Rebecca, Chenouard, Nicolas, Sun, Simón E D, Jones, Drew, Buzsáki, György, Devinsky, Orrin, Woodhall, Gavin, Scharfman, Helen E, Whalley, Benjamin J, Tsien, Richard W
- Database ID:
- RTHC-04897
Evidence Hierarchy
Frequently Asked Questions
How does CBD prevent seizures?
This study showed CBD blocks a lipid called LPI from activating GPR55 receptors, which simultaneously prevents excessive excitatory signaling and preserves inhibitory signaling in the hippocampus.
Could this lead to better epilepsy drugs?
If GPR55 is a key target, drugs that specifically block this receptor could potentially replicate CBD's anti-seizure effects with fewer drug interactions than CBD itself.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04897APA
Rosenberg, Evan C; Chamberland, Simon; Bazelot, Michael; Nebet, Erica R; Wang, Xiaohan; McKenzie, Sam; Jain, Swati; Greenhill, Stuart; Wilson, Max; Marley, Nicole; Salah, Alejandro; Bailey, Shanice; Patra, Pabitra Hriday; Rose, Rebecca; Chenouard, Nicolas; Sun, Simón E D; Jones, Drew; Buzsáki, György; Devinsky, Orrin; Woodhall, Gavin; Scharfman, Helen E; Whalley, Benjamin J; Tsien, Richard W. (2023). Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.. Neuron, 111(8), 1282-1300.e8. https://doi.org/10.1016/j.neuron.2023.01.018
MLA
Rosenberg, Evan C, et al. "Cannabidiol modulates excitatory-inhibitory ratio to counter hippocampal hyperactivity.." Neuron, 2023. https://doi.org/10.1016/j.neuron.2023.01.018
RethinkTHC
RethinkTHC Research Database. "Cannabidiol modulates excitatory-inhibitory ratio to counter..." RTHC-04897. Retrieved from https://rethinkthc.com/research/rosenberg-2023-cannabidiol-modulates-excitatoryinhibitory-ratio
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.